Pouya Motazedian Profile
Pouya Motazedian

@_profmota

Followers
23
Following
17
Media
0
Statuses
6

Cardiology Resident | University of Ottawa Heart Institute

Ottawa, Ontario, Canada
Joined May 2023
Don't wanna be here? Send us removal request.
@benhibbertMDPhD
Benjamin Hibbert
1 year
#VTstorm is a common problem in #CICU #critcarecardio. SGB is purported to be a treatment for this condition. @_profmota reports in @SciReports @NaturePortfolio an overview of data supporting this strategy. https://t.co/FGvvznOFe5 for the open access PDF
3
8
41
@benhibbertMDPhD
Benjamin Hibbert
2 years
How can we improve #POCUS utility and democratize application - #AI augmentation! Both senior and novice scanners can rapidly and accurately measure and classify LVEF across clinical settings (echo lab, ward, ED, ICU).
1
19
38
@ACCinTouch
American College of Cardiology
2 years
Pulmonary vein stenosis can arise from several etiologies, including congenital, acquired & iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. Read more on PVS in #JACC: https://t.co/OeDTSMBqDj
0
58
188
@JAMarbach
Jeffrey Marbach
2 years
The five year follow up https://t.co/LzsXmreQwZ to our initial publication on the impact of a formal research curriculum in cardiology training https://t.co/7ad8j2clCz @tjsimard @benhibbertMDPhD @JCigarroaMD
0
2
11
@tjsimard
Trevor Simard
2 years
Our report on a rabbit model for evaluation of stent healing using optical coherence tomography (OCT). Several observations to help guide pragmatic translational study design. Great work by the team to bring this analysis of >1,000 stent segments together. https://t.co/5X5r95ApEh
0
7
30
@sdparlow
Simon Parlow
3 years
Introducing CAPITAL DOREMI2: a follow-up to the DOREMI trial published in NEJM. This is a randomized clinical trial comparing inotrope therapy to placebo in the initial 12-hour resuscitation of patients with SCAI C or D cardiogenic shock
2
23
77